About CCKR THERAPEUTICS INC
CCKr Therapeutics LLC is a biotechnology company focused on developing Proglumide, a small molecule repurposed drug with oral bioavailability and multiple mechanisms of action, targeting GI cancer, fibrosis, and pain management. The company emphasizes regulatory advantages and fast-track potential for its therapeutic platform.
Development of Proglumide, a small molecule with oral bioavailabilityTargeting CCK-A and CCK-B receptors for cancer cell proliferation reduction and fibrosis treatmentAddressing fibrosis through receptor-dependent and receptor-independent mechanismsPotential for pain management by reducing opioid dependencyRegulatory strategy development and FDA pre-meeting submissions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CCKR THERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.